Type I interferon and pattern recognition receptor signaling following particulate matter inhalation

Particle and Fibre Toxicology

Volumn 9, Issue , 2012, Pages

  Erdely, Aaron ^a,b   Antonini, James M ^a   Salmen Muniz, Rebecca ^a   Liston, Angie ^a   Hulderman, Tracy ^a   Simeonova, Petia P ^a   Kashon, Michael L ^a   Li, Shengqiao ^a   Gu, Ja K ^a   Stone, Samuel ^a   Chen, Bean T ^a   Frazer, David G ^a   Zeidler Erdely, Patti C ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Aorta; Biomarker; Cardiovascular disease; Chromium; Inhalation; Interferon regulatory factor 7; Microarray; Pattern recognition receptor; Welding; Whole blood cell gene expression

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; C REACTIVE PROTEIN; CRYOPYRIN; DECTIN 1; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE B; INTERFERON; INTERFERON STIMULATED GENE FACTOR 3; MYELOID DIFFERENTIATION FACTOR 88; ONCOSTATIN M; PATTERN RECOGNITION RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; STAINLESS STEEL; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 7; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CLEC7A GENE; CONTROLLED STUDY; DDX58 GENE; DHX58 GENE; EXPOSURE; GENE EXPRESSION; ISGF3 GENE; LFIH1 GENE; LRF7 GENE; LUNG; MALE; MOUSE; MYD88 GENE; NLRP3 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARTICULATE MATTER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TLR2 GENE; TLR7 GENE; WELDING FUME;

ANIMALS; AORTA; BLOOD CELLS; BLOOD PROTEINS; CLUSTER ANALYSIS; DATA INTERPRETATION, STATISTICAL; INHALATION EXPOSURE; INTERFERON REGULATORY FACTOR-7; INTERFERON TYPE I; LUNG; MALE; MICE; MICE, INBRED C57BL; PARTICULATE MATTER; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, PATTERN RECOGNITION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOXICITY TESTS; TRANSCRIPTOME; WELDING;

MUS;

EID: 84863524525     PISSN: None     EISSN: 17438977     Source Type: Journal    
DOI: 10.1186/1743-8977-9-25     Document Type: Article

References (51)

1. Antonini JM. Health effects of welding. Crit Rev Toxicol 2003, 33:61-103.
2. Antonini JM, Stone S, Roberts JR, Chen B, Schwegler-Berry D, Afshari AA, Frazer DG. Effect of short-term stainless steel welding fume inhalation exposure on lung inflammation, injury, and defense responses in rats. Toxicol Appl Pharmacol 2007, 223:234-245.
3. Zeidler-Erdely PC, Battelli LA, Stone S, Chen BT, Frazer DG, Young SH, Erdely A, Kashon ML, Andrews R, Antonini JM. Short-term inhalation of stainless steel welding fume causes sustained lung toxicity but no tumorigenesis in lung tumor susceptible A/J mice. Inhal Toxicol 2011, 23:112-120.
4. Hilt B, Qvenild T, Romyhr O. Morbidity from ischemic heart disease in workers at a stainless steel welding factory. Norsk Epidemiologi 1999, 9:21-26.
5. Ibfelt E, Bonde JP, Hansen J. Exposure to metal welding fume particles and risk for cardiovascular disease in Denmark: a prospective cohort study. Occup Environ Med 2010, 67:772-777.
6. Sjogren B, Fossum T, Lindh T, Weiner J. Welding and ischemic heart disease. Int J Occup Environ Health 2002, 8:309-311.
7. du Plessis L, Laubscher P, Jooste J, du Plessis J, Franken A, van Aarde N, Eloff F. Flow cytometric analysis of the oxidative status in human peripheral blood mononuclear cells of workers exposed to welding fumes. J Occup Environ Hyg 2010, 7:367-374.
8. Erdely A, Hulderman T, Salmen-Muniz R, Liston A, Zeidler-Erdely PC, Chen BT, Stone S, Frazer DG, Antonini JM, Simeonova PP. Inhalation exposure of gas-metal arc stainless steel welding fume increased atherosclerotic lesions in apolipoprotein E knockout mice. Toxicol Lett 2011, 204:12-16.
9. Fang SC, Cavallari JM, Eisen EA, Chen JC, Mittleman MA, Christiani DC. Vascular function, inflammation, and variations in cardiac autonomic responses to particulate matter among welders. Am J Epidemiol 2009, 169:848-856.
10. Kim JY, Chen JC, Boyce PD, Christiani DC. Exposure to welding fumes is associated with acute systemic inflammatory responses. Occup Environ Med 2005, 62:157-163.
11. Magari SR, Hauser R, Schwartz J, Williams PL, Smith TJ, Christiani DC. Association of heart rate variability with occupational and environmental exposure to particulate air pollution. Circulation 2001, 104:986-991.
12. Anderson SE, Meade BJ, Butterworth LF, Munson AE. The humoral immune response of mice exposed to manual metal arc stainless steel-welding fumes. Journal of Immunotoxicology 2007, 4:15-23.
13. Antonini JM, Roberts JR, Stone S, Chen BT, Schwegler-Berry D, Frazer DG. Short-Term Inhalation Exposure to Mild Steel Welding Fume had no Effect on Lung Inflammation and Injury but did Alter Defense Responses to Bacteria in Rats. Inhalation Toxicology 2009, 21:182-192.
14. Erdely A, Hulderman T, Salmen R, Liston A, Zeidler-Erdely PC, Schwegler-Berry D, Castranova V, Koyama S, Kim YA, Endo M, Simeonova PP. Cross-talk between lung and systemic circulation during carbon nanotube respiratory exposure. Potential biomarkers. Nano Lett 2009, 9:36-43.
15. Erdely A, Liston A, Salmen-Muniz R, Hulderman T, Young SH, Zeidler-Erdely PC, Castranova V, Simeonova PP. Identification of systemic markers from a pulmonary carbon nanotube exposure. J Occup Environ Med 2011, 53:S80-S86.
16. Korczynski RE. Occupational health concerns in the welding industry. Appl Occup Environ Hyg 2000, 15:936-945.
17. Susi P, Goldberg M, Barnes P, Stafford E. The use of a task-based exposure assessment model (T-BEAM) for assessment of metal fume exposures during welding and thermal cutting. Appl Occup Environ Hyg 2000, 15:26-38.
18. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005, 434:772-777.
19. Erdely A, Salmen-Muniz R, Liston A, Hulderman T, Zeidler-Erdely PC, Antonini JM, Simeonova PP. Relationship between pulmonary and systemic markers of exposure to multiple types of welding particulate matter. Toxicology 2011, 287:153-159.
20. Calabresi PA, Tranquill LR, Dambrosia JM, Stone LA, Maloni H, Bash CN, Frank JA, McFarland HF. Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b. Annals of Neurology 1997, 41:669-674.
21. Markman M, Belinson J, Webster K, Zanotti K, Morrison B, Jacobs B, Borden E, Lindner D. Phase 2 trial of interferon-beta as second-line treatment of ovarian cancer, fallopian tube cancer, or primary carcinoma of the peritoneum. Oncology 2004, 66:343-346.
22. Soilu-Hanninen M, Koskinen JO, Laaksonen M, Hanninen A, Lilius EM, Waris M. High sensitivity measurement of CRP and disease progression in multiple sclerosis. Neurology 2005, 65:153-155.
23. Tak PP, 't Hart BA, Kraan MC, Jonker M, Smeets TJM, Breedveld FC. The effects of interferon beta treatment on arthritis. Rheumatology 1999, 38:362-369.
24. Trojano M, Avolio C, Liuzzi GM, Ruggieri M, Defazio G, Liguori M, Santacroce MP, Paolicelli D, Giuliani F, Riccio P, Livrea P. Changes of serum sICAM-1 and MMP-9 induced by rIFN beta-1b treatment in relapsing-remitting MS. Neurology 1999, 53:1402-1408.
25. Larrea E, Aldabe R, Gonzalez I, Segura V, Sarobe P, Echeverria I, Prieto J. Oncostatin M Enhances the Antiviral Effects of Type I Interferon and Activates Immunostimulatory Functions in Liver Epithelial Cells. Journal of Virology 2009, 83:3298-3311.
26. Honda K, Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nature Reviews Immunology 2006, 6:644-658.
27. Opitz B, van Laak V, Eitel J, Suttorp N. Innate Immune Recognition in Infectious and Noninfectious Diseases of the Lung. American Journal of Respiratory and Critical Care Medicine 2010, 181:1294-1309.
28. Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, Tephly LA, Carter AB, Rothman PB, Flavell RA, Sutterwala FS. The Nalp3 inflammasome is essential for the development of silicosis. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:9035-9040.
29. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320:674-677.
30. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, Latz E. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nature Immunology 2008, 9:847-856.
31. Cho HY, Jedlicka AE, Clarke R, Kleeberger SR. Role of Toll-like receptor-4 in genetic susceptibility to lung injury induced by residual oil fly ash. Physiological Genomics 2005, 22:108-117.
32. Doz E, Noulin N, Boichbt E, Guenon I, Fick L, Le Bert M, Lagente V, Ryffel B, Schnyder B, Quesniaux VFJ, Couillin I. Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. Journal of Immunology 2008, 180:1169-1178.
33. Kampfrath T, Maiseyeu A, Ying ZK, Shah Z, Deiuliis JA, Xu XH, Kherada N, Brook RD, Reddy KM, Padture NP, Parthasarathy S, Chen LC, Moffatt-Bruce S, Sun QH, Morawietz H, Rajagopalan S. Chronic Fine Particulate Matter Exposure Induces Systemic Vascular Dysfunction via NADPH Oxidase and TLR4 Pathways. Circulation Research 2011, 108:716-726.
34. Taylor MD, Roberts JR, Leonard SS, Shi XL, Antonini JM. Effects of welding fumes of differing composition and solubility on free radical production and acute lung injury and inflammation in rats. Toxicological Sciences 2003, 75:181-191.
35. Giordano G, van den Brule S, Lo Re S, Triqueneaux P, Uwambayinema F, Yakoub Y, Couillin I, Ryffel B, Michiels T, Renauld JC, Lison D, Huaux F. Type I Interferon Signaling Contributes to Chronic Inflammation in a Murine Model of Silicosis. Toxicological Sciences 2010, 116:682-692.
36. Nemec AA, Zubritsky LM, Barchowsky A. Chromium(VI) Stimulates Fyn to Initiate Innate Immune Gene Induction in Human Airway Epithelial Cells. Chemical Research in Toxicology 2010, 23:396-404.
37. Keane M, Stone S, Chen B, Slaven J, Schwegler-Berry D, Antonini J. Hexavalent chromium content in stainless steel welding fumes is dependent on the welding process and shield gas type. J Environ Monit 2009, 11:418-424.
38. Colina R, Costa-Mattioli M, Dowling RJO, Jaramillo M, Tai LH, Breitbach CJ, Martineau Y, Larsson O, Rong LW, Svitkin YV, Makrigiannis AP, Bell JC, Sonenberg N. Translational control of the innate immune response through IRF-7. Nature 2008, 452:323-U322.
39. Matikainen S, Siren J, Tissari J, Veckman V, Pirhonen J, Severa M, Sun Q, Lin RT, Meri S, Uze G, Hiscott J, Julkunen I. Tumor necrosis factor alpha enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression. Journal of Virology 2006, 80:3515-3522.
40. Brook RD, Rajagopalan S, Pope CA, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA, Peters A, Siscovick D, Smith SC, Whitsel L, Kaufman JD. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation 2010, 121:2331-2378.
41. Mzhavia N, Yu SQ, Ikeda S, Chu TT, Goldberg I, Dansky HM. Neuronatin: A new inflammation gene expressed on the aortic endothelium of diabetic mice. Diabetes 2008, 57:2774-2783.
42. Heinig M, Petretto E, Wallace C, Bottolo L, Rotival M, Lu H, Li YY, Sarwar R, Langley SR, Bauerfeind A, Hummel O, Lee YA, Paskas S, Rintisch C, Saar K, Cooper J, Buchan R, Gray EE, Cyster JG, Erdmann J, Hengstenberg C, Maouche S, Ouwehand WH, Rice CM, Samani NJ, Schunkert H, Goodall AH, Schulz H, Roider HG, Vingron M, et al. A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk. Nature 2010, 467:460-464.
43. Buss C, Opitz B, Hocke AC, Lippmann J, van Laak V, Hippenstiel S, Krull M, Suttorp N, Eitel J. Essential role of mitochondrial antiviral signaling, IFN regulatory factor (IRF)3, and IRF7 in Chlamydophila pneumoniae-mediated IFN-beta response and control of bacterial replication in human endothelial cells. Journal of Immunology 2010, 184:3072-3078.
44. Borska L, Fiala Z, Ctirad A, Krejsek J, Tejral J. Health risk of occupational exposure in welding processes II. Immunological effects. Acta Medica (Hradec Kralove) 2003, 46:31-35.
45. Shvedova AA, Fabisiak JP, Kisin ER, Murray AR, Roberts JR, Tyurina YY, Antonini JM, Feng WH, Kommineni C, Reynolds J, Barchowsky A, Castranova V, Kagan VE. Sequential exposure to carbon nanotubes and bacteria enhances pulmonary inflammation and infectivity. American Journal of Respiratory Cell and Molecular Biology 2008, 38:579-590.
46. Auerbuch V, Brockstedt DG, Meyer-Morse N, O'Riordan M, Portnoy DA. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. Journal of Experimental Medicine 2004, 200:527-533.
47. McRae BL, Nagai T, Semnani RT, van Seventer JM, van Seventer GA. Interferon-alpha and -beta inhibit the in vitro differentiation of immunocompetent human dendritic cells from CD14(+) precursors. Blood 2000, 96:210-217.
48. Noraz N, Lathey JL, Spector SA. Human cytomegalovirus-associated immunosuppression is mediated through interferon-alpha. Blood 1997, 89:2443-2452.
49. Antonini JM, Afshari AA, Stone S, Chen B, Schwegler-Berry D, Fletcher WG, Goldsmith WT, Vandestouwe KH, McKinney W, Castranova V, Frazer DG. Design, construction, and characterization of a novel robotic welding fume generator and inhalation exposure system for laboratory animals. J Occup Environ Hyg 2006, 3:194-203. quiz D145.
50. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008, 3:1101-1108.
51. Zeidler-Erdely PC, Kashon ML, Li S, Antonini JM. Response of the mouse lung transcriptome to welding fume: effects of stainless and mild steel fumes on lung gene expression in A/J and C57BL/6 J mice. Respir Res 2010, 11:70.